vs

Side-by-side financial comparison of BrightView Holdings, Inc. (BV) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

BrightView Holdings, Inc. is the larger business by last-quarter revenue ($614.7M vs $321.1M, roughly 1.9× MADRIGAL PHARMACEUTICALS, INC.). BrightView Holdings, Inc. runs the higher net margin — -2.5% vs -18.2%, a 15.8% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 2.6%). BrightView Holdings, Inc. produced more free cash flow last quarter ($-18.6M vs $-133.8M).

BrightView Holdings, Inc. is a leading US commercial landscaping services provider. It offers solutions including landscape design, installation, maintenance, irrigation management, and snow and ice removal, serving corporate campuses, retail centers, residential communities, and public sector properties.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

BV vs MDGL — Head-to-Head

Bigger by revenue
BV
BV
1.9× larger
BV
$614.7M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+208.2% gap
MDGL
210.8%
2.6%
BV
Higher net margin
BV
BV
15.8% more per $
BV
-2.5%
-18.2%
MDGL
More free cash flow
BV
BV
$115.3M more FCF
BV
$-18.6M
$-133.8M
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BV
BV
MDGL
MDGL
Revenue
$614.7M
$321.1M
Net Profit
$-15.2M
$-58.6M
Gross Margin
18.6%
Operating Margin
-1.2%
-18.6%
Net Margin
-2.5%
-18.2%
Revenue YoY
2.6%
210.8%
Net Profit YoY
-46.2%
1.4%
EPS (diluted)
$-0.26
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BV
BV
MDGL
MDGL
Q4 25
$614.7M
$321.1M
Q3 25
$702.7M
$287.3M
Q2 25
$708.3M
$212.8M
Q1 25
$662.6M
$137.3M
Q4 24
$599.2M
$103.3M
Q3 24
$728.7M
$62.2M
Q2 24
$738.8M
Q1 24
$672.9M
$0
Net Profit
BV
BV
MDGL
MDGL
Q4 25
$-15.2M
$-58.6M
Q3 25
$27.7M
$-114.2M
Q2 25
$32.3M
$-42.3M
Q1 25
$6.4M
$-73.2M
Q4 24
$-10.4M
$-59.4M
Q3 24
$25.6M
$-107.0M
Q2 24
$23.5M
Q1 24
$33.7M
$-147.5M
Gross Margin
BV
BV
MDGL
MDGL
Q4 25
18.6%
Q3 25
25.1%
Q2 25
24.1%
Q1 25
22.3%
96.7%
Q4 24
21.2%
Q3 24
25.0%
Q2 24
24.0%
Q1 24
22.6%
Operating Margin
BV
BV
MDGL
MDGL
Q4 25
-1.2%
-18.6%
Q3 25
7.9%
-39.7%
Q2 25
8.1%
-22.2%
Q1 25
3.4%
-57.8%
Q4 24
-0.1%
-64.8%
Q3 24
7.1%
-187.1%
Q2 24
6.6%
Q1 24
9.2%
Net Margin
BV
BV
MDGL
MDGL
Q4 25
-2.5%
-18.2%
Q3 25
3.9%
-39.8%
Q2 25
4.6%
-19.9%
Q1 25
1.0%
-53.4%
Q4 24
-1.7%
-57.5%
Q3 24
3.5%
-172.0%
Q2 24
3.2%
Q1 24
5.0%
EPS (diluted)
BV
BV
MDGL
MDGL
Q4 25
$-0.26
$-2.55
Q3 25
$0.21
$-5.08
Q2 25
$0.15
$-1.90
Q1 25
$-0.03
$-3.32
Q4 24
$-0.20
$-2.50
Q3 24
$0.20
$-4.92
Q2 24
$0.10
Q1 24
$0.17
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BV
BV
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$37.0M
$198.7M
Total DebtLower is stronger
$801.1M
$339.9M
Stockholders' EquityBook value
$1.3B
$602.7M
Total Assets
$3.3B
$1.3B
Debt / EquityLower = less leverage
0.64×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BV
BV
MDGL
MDGL
Q4 25
$37.0M
$198.7M
Q3 25
$74.5M
$295.7M
Q2 25
$79.1M
$186.2M
Q1 25
$141.3M
$183.6M
Q4 24
$98.3M
$100.0M
Q3 24
$140.4M
$232.7M
Q2 24
$115.9M
Q1 24
$177.3M
$622.5M
Total Debt
BV
BV
MDGL
MDGL
Q4 25
$801.1M
$339.9M
Q3 25
$790.2M
$339.8M
Q2 25
$790.7M
$118.4M
Q1 25
$798.9M
$118.0M
Q4 24
$796.5M
$117.6M
Q3 24
$802.5M
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
BV
BV
MDGL
MDGL
Q4 25
$1.3B
$602.7M
Q3 25
$1.3B
$625.7M
Q2 25
$1.3B
$696.0M
Q1 25
$1.3B
$710.6M
Q4 24
$1.3B
$754.4M
Q3 24
$1.3B
$777.2M
Q2 24
$1.3B
Q1 24
$1.2B
$850.8M
Total Assets
BV
BV
MDGL
MDGL
Q4 25
$3.3B
$1.3B
Q3 25
$3.4B
$1.4B
Q2 25
$3.4B
$1.0B
Q1 25
$3.3B
$996.6M
Q4 24
$3.3B
$1.0B
Q3 24
$3.4B
$1.1B
Q2 24
$3.4B
Q1 24
$3.4B
$1.1B
Debt / Equity
BV
BV
MDGL
MDGL
Q4 25
0.64×
0.56×
Q3 25
0.61×
0.54×
Q2 25
0.62×
0.17×
Q1 25
0.63×
0.17×
Q4 24
0.63×
0.16×
Q3 24
0.63×
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BV
BV
MDGL
MDGL
Operating Cash FlowLast quarter
$36.1M
$-133.5M
Free Cash FlowOCF − Capex
$-18.6M
$-133.8M
FCF MarginFCF / Revenue
-3.0%
-41.7%
Capex IntensityCapex / Revenue
8.9%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BV
BV
MDGL
MDGL
Q4 25
$36.1M
$-133.5M
Q3 25
$84.4M
$79.8M
Q2 25
$55.7M
$-47.1M
Q1 25
$91.2M
$-88.9M
Q4 24
$60.5M
$-104.5M
Q3 24
$53.5M
$-67.0M
Q2 24
$42.6M
Q1 24
$83.3M
$-149.2M
Free Cash Flow
BV
BV
MDGL
MDGL
Q4 25
$-18.6M
$-133.8M
Q3 25
$26.0M
$79.0M
Q2 25
$-47.8M
Q1 25
$57.6M
Q4 24
$1.8M
$-104.7M
Q3 24
$21.1M
$-67.8M
Q2 24
$19.3M
Q1 24
$70.7M
$-149.5M
FCF Margin
BV
BV
MDGL
MDGL
Q4 25
-3.0%
-41.7%
Q3 25
3.7%
27.5%
Q2 25
-6.7%
Q1 25
8.7%
Q4 24
0.3%
-101.3%
Q3 24
2.9%
-109.0%
Q2 24
2.6%
Q1 24
10.5%
Capex Intensity
BV
BV
MDGL
MDGL
Q4 25
8.9%
0.1%
Q3 25
8.3%
0.3%
Q2 25
14.6%
0.0%
Q1 25
5.1%
0.0%
Q4 24
9.8%
0.2%
Q3 24
4.4%
1.3%
Q2 24
3.2%
Q1 24
1.9%
Cash Conversion
BV
BV
MDGL
MDGL
Q4 25
Q3 25
3.05×
Q2 25
1.72×
Q1 25
14.25×
Q4 24
Q3 24
2.09×
Q2 24
1.81×
Q1 24
2.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BV
BV

Landscape Maintenance$368.0M60%
Development Services Segment$179.2M29%
Snow Removal$68.4M11%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons